Home EuroPCR 2026: DynamX Bioadaptor Shows 66% Lower TLF vs. DES with Full Vessel Function Restoration at 4 Years

EuroPCR 2026: DynamX Bioadaptor Shows 66% Lower TLF vs. DES with Full Vessel Function Restoration at 4 Years

May 31, 2026 08:00 CST Updated 10:11
Elixir Medical

Medical Device R&D and Manufacturing Company